The issue of breast cancer metastasis?
Hello Dr.
Chen: My mother had surgery a month ago and her AJCC stage is yT2N1aMx.
I would like to ask what the "y" in front signifies.
Also, I have checked that "Mx" means that it is not possible to determine if there are distant metastases.
What does this mean? Before the surgery, a full-body examination was conducted, and it was stated that there were no distant metastases.
Why would the physician write "unable to assess" on the surgical pathology report? Does this imply that there is a possibility of distant metastasis? Or could it be related to the fact that my mother had some redness and bleeding on her skin when she sought medical attention at Hsin-Chu Hospital? (Due to work commitments, I am unable to accompany my mother to the hospital, and she does not understand these terms, which is why I am reaching out to the doctor.) Thank you, doctor!
Da Ming, 20~29 year old female. Ask Date: 2008/11/16
Dr. Chen Sirong reply Oncology
1.
"y" refers to pathological staging.
2.
Pathological staging is determined by pathologists based on the specimens sent by the surgeon after surgery.
Since the surgeon does not send the entire body for examination, but only the surgical specimen, the pathologist can only assess the T tumor and the adjacent lymph nodes.
Therefore, the pathologist can only state that it is not possible to determine whether there is distant metastasis.
3.
The surgeon has examined the entire body, so they can state M0.
Further chemotherapy is needed.
It is important to provide her with encouragement, support, and companionship.
Wishing her a speedy recovery.
Dr.
Chen.
Reply Date: 2008/11/16
More Info
Understanding breast cancer staging can be quite complex, especially when interpreting the AJCC (American Joint Committee on Cancer) staging system. In your mother's case, the notation "yT2N1aMx" provides specific information about her cancer's characteristics and extent.
1. The Meaning of 'y': The 'y' in the staging notation indicates that this is a "post-treatment" or "pathological" stage. It signifies that the staging is based on the findings after the surgical intervention, which in this case is the surgery your mother underwent. This is important because it reflects the current status of the cancer after treatment, rather than the initial diagnosis.
2. Understanding 'Mx': The 'Mx' indicates that the presence of distant metastasis cannot be assessed. This means that the medical team was unable to determine whether there are any distant metastases (spread of cancer to other parts of the body) based on the available information. It's not uncommon for this designation to appear in surgical pathology reports, especially if comprehensive imaging studies were not performed or if the findings were inconclusive.
3. Why the Uncertainty? You mentioned that prior to the surgery, a full-body examination indicated no distant metastasis. However, the surgical pathology report's designation of 'Mx' suggests that while there was no definitive evidence of metastasis at the time of surgery, the pathologists were unable to confirm this with certainty based on the tissue samples they examined. This could be due to several reasons, including the nature of the cancer, the extent of the surgical samples taken, or the presence of symptoms such as the redness and bleeding you noted on your mother's skin. These symptoms could indicate localized issues that might warrant further investigation.
4. Possibility of Distant Metastasis: The designation 'Mx' does not necessarily mean that there is distant metastasis; it simply indicates that the assessment was inconclusive. The surgical team may have had reasons to believe that there was no distant spread based on imaging and clinical evaluations, but the pathology report reflects a cautious approach. It is essential to follow up with the oncologist to discuss the next steps, which may include further imaging studies or monitoring.
5. Next Steps and Support: Given that your mother is at AJCC stage yT2N1a, it indicates that she has a tumor size of T2 (between 2 and 5 cm) and N1a (indicating involvement of nearby lymph nodes). This stage often requires additional treatment, such as chemotherapy, to reduce the risk of recurrence and manage any potential metastasis. It's crucial to provide emotional support to your mother during this time, as navigating cancer treatment can be overwhelming.
6. Communication with Healthcare Providers: Since you are unable to accompany your mother to her appointments, it may be beneficial to encourage her to ask questions during her visits or to write down any concerns she has beforehand. Additionally, you could consider requesting a summary of her medical discussions to stay informed about her condition and treatment plan.
In summary, the 'y' indicates a post-treatment assessment, while 'Mx' signifies that the presence of distant metastasis could not be determined. It's important to maintain open communication with her healthcare team to understand her situation better and to ensure she receives the appropriate follow-up care.
Similar Q&A
Understanding Breast Cancer Staging and Hormonal Therapy Options
Hello, doctor. I would like to ask about a recent biopsy that revealed a 0.7 cm malignant tumor in my right breast. I am currently undergoing hormone therapy. I was previously a breast cancer patient, with the original cancer located in the left breast axilla, and it was diagnose...
Dr. Yuan Tianmin reply Breast and Thyroid
Based on the information you provided, it may still be necessary for you to return to the original hospital for staging, as there is a lot of data that has not been reviewed.[Read More] Understanding Breast Cancer Staging and Hormonal Therapy Options
Understanding Breast Cancer Staging and HER-3: Key Questions Answered
Dear Dr. Wu, My mother is 78 years old and underwent surgery for left breast cancer at the end of last month. During the consultation of the pathology report, the doctor mentioned it was stage II, with no lymph node metastasis. Given my mother's advanced age and the absence...
Dr. Wu Jingtang reply Breast and Thyroid
Dr. Yuan: 1. The staging of breast cancer is also related to tumor size. Physicians determine the stage based on tumor size, lymph node involvement, and distant metastasis. 2. Her-2/neu is a specific receptor; in breast cancer patients, a score of 3+ indicates "positive,&quo...[Read More] Understanding Breast Cancer Staging and HER-3: Key Questions Answered
Accuracy of MRI in Detecting Lymph Node Metastasis in Tongue Cancer
Hello, doctor! My father is scheduled for surgery at the end of the month due to stage I tongue cancer. The doctor has performed ultrasound, bone scans, X-rays, and MRI, and they all indicate it is stage I. However, I read online that clinical staging primarily focuses on lymphat...
Dr. Chen Jianzhi reply Otolaryngology
Dear Inquirer, Cancer staging can be categorized into several types: clinical staging, imaging staging, surgical pathological staging, and others. MRI and PET scans fall under imaging staging. However, surgical pathological staging is the most accurate. Therefore, if the clinica...[Read More] Accuracy of MRI in Detecting Lymph Node Metastasis in Tongue Cancer
Understanding Pathology Reports for Rectal Cancer: TNM Staging Explained
Dear Doctor: My father was recently diagnosed with rectal cancer, and the pathology report after surgery indicated a TNM staging of T1N1aMx, which corresponds to stage 3A. I have a few questions: 1. Why is the result for M marked as x? Isn't there usually a preoperative exam...
Dr. Ke Fangxu reply Surgery
1. The "x" indicates that there was no examination performed because the surgeon did not send suspicious tissue for distant metastasis, leaving the pathologist unable to conduct an examination. If the surgeon had marked the suspicious tissue for distant metastasis, the ...[Read More] Understanding Pathology Reports for Rectal Cancer: TNM Staging Explained
Related FAQ
(Oncology)
Terminal Stage(Oncology)
Uterus(Oncology)
Axillary Lump(Oncology)
Breast Cancer(Surgery)
Neck Mass(Oncology)
Lymph Nodes(Oncology)
Fibroadenoma(Breast and Thyroid)
Endometrial Cancer(Obstetrics and Gynecology)
Pancreatic Cancer(Oncology)